| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |